Search results for query: *

  1. C

    Exploring a Research-Informed Supplement — Gauging Interest (No Claims)

    Thank you for the feedback — that’s absolutely fair. The intention here isn’t to collect contacts or overstep any boundaries, but rather to gauge early interest while we continue progressing through the preclinical and early development stages. At this point, we’re working with a few...
  2. C

    Exploring a Research-Informed Supplement — Gauging Interest (No Claims)

    The reason we developed our own outcome measure rather than using something like ALS-FRS or ROADS is that we didn’t want to pigeonhole the product into one specific disease state this early on. Since the product is designed to support general neuromuscular and functional health, we felt a...
  3. C

    Exploring a Research-Informed Supplement — Gauging Interest (No Claims)

    Thank you — that’s a great question, and exactly the direction we’d like to go. Right now, we’ve actually developed a functional outcome measure that we plan to use for early users, assuming the product performs well once it’s available. The ultimate hope is that if we see enough early benefit...
  4. C

    Exploring a Research-Informed Supplement — Gauging Interest (No Claims)

    Hi everyone — I just wanted to briefly share that I’m working with a small team on developing a supplement aimed at supporting muscle health, energy metabolism, and cellular maintenance pathways. Like many of you, I know we’ve all seen a lot of bold claims and false hope in this space before —...
Back
Top